Neuraxpharm and Dizlin Pharmaceuticals Forge a New Path in Parkinson's Care with Innovative Therapy Neuraxpharm and Dizlin Pharmaceuticals have teamed up to develop Infudopa SubC®, a breakthrough therapy for patients with advanced Parkinson's disease, enhancing patient independence.

Neuraxpharm and Dizlin Pharmaceuticals Forge a New Path in Parkinson's Care with Innovative Therapy #Germany #Düsseldorf #Parkinson's #Neuraxpharm #Dizlin